Micol Rothman is an Endocrinology/Metabolic physician affiliated with University of Colorado Anschutz Medical Campus. OpenAlex indexes 96 publications with 1,770 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12605 E 16th Ave
Aurora, CO 800452545
Telephone
720-848-0000Registry record last updated 18 Dec 2012.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Antares Pharma, Inc.Program year20241 payment
- Radius Health, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
44.3%l-Thyroxine23.4%Levothyroxine Sodium63%Synthroid37%Part D≥25 patientsParathyroid Hormone Analog13.2%Teriparatide62%Forteo38%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
25.8%GLP-1 receptor agonist8.2%Ozempic47%Mounjaro29%Trulicity24%Part D<11 patientsBiguanide (metformin)6%Metformin Hcl57%Metformin Hcl Er43%Part D<11 patients+ 4 more classes in this area
Cardiovascular
16.2%Statin7.9%Rosuvastatin Calcium55%Atorvastatin Calcium45%Part D<11 patientsAldosterone antagonist (MRA)4.1%Spironolactone100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Injectable Estradiol Use in Transgender and Gender-Diverse Individuals throughout the United States
The Journal of Clinical Endocrinology & Metabolism
2025 - Bone Density in Transgender Youth on Gender-Affirming Hormone Therapy
Journal of the Endocrine Society
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Schulick, MD, MBA
University of Colorado Anschutz Medical Campus
John Rumsfeld, MD, PhD
University of Colorado Anschutz Medical Campus
Robert Eckel, MD
University of Colorado Anschutz Medical Campus
Marc Bonaca, MD
University of Colorado Anschutz Medical Campus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”